Contact Us
Patients Health Care Professionals Corporate Tissue Services Career Opportunities
Search
AlloDerm®Tissue Matrix defined
Applications and procedures
Abdominal wall reconstruction
Breast reconstruction
ENT/head and neck
Using AlloDerm® Tissue Matrix in the OR
Product catalog
Customer support
Reimbursement information
FAQs
For challenging hernia repair, choose AlloDerm® Regenerative Tissue Matrix

AlloDerm® Tissue Matrix is derived from cadaveric dermis and undergoes non-damaging proprietary processing that removes cells. AlloDerm® Tissue Matrix provides a strong and safe hernia repair and may minimize the risk of short- and long-term complications.1,2,3

As shown in animal studies, AlloDerm® Tissue Matrix supports tissue regeneration by allowing rapid revascularization, white cell migration and cell repopulation, which may minimize the risk of infection4,5,6,7,8
  • Rapid revascularization through existing vascular channels and new blood vessel formation
  • Rapid revascularization allows white blood cells to migrate to the site
Photo of AlloDerm® Tissue Matrix in a human patient. Bleeding AlloDerm® Tissue Matrix four weeks postimplantation.


Animal studies show a low incidence in adhesion to the implant.

Photo Right: Polypropylene mesh with AlloDerm® Tissue Matrix in a guinea pig model.


Photos of exposed AlloDerm® Tissue Matrix in a human patient taken at different time intervals monitor wound progression. Wound closed over the course of 3 months.


  1. Silverman RP et al. Ventral hernia repair using allogenic acellular dermal matrix in a swine model. Hernia. 2004;8:336-342.
  2. Holton LH 3rd et al. Human acellular dermal matrix for repair of abdominal wall defects: review of clinical experience and experimental data. LongTerm EffMed Implants. 2005; 15(5): 547-558.
  3. Buinewicz B, Rosen B. Acellular cadaveric dermis (AlloDerm™®): a new alternative for abdominal hernia repair. Ann Plast Surg. 2004 Feb;52(2):188-194.
  4. Menon NG et al. Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann Plast Surg. 2003 May;50(5):523-527.
  5. Diaz JJ Jr et al. Acellular dermal allograft for ventral hernia repair in the compromised surgical field. Am Surg. 2006 Dec;72(12):1181-1188.
  6. Kim H et al. Acellular dermal matrix in the management of high-risk abdominal wall defects. Am J Surg. 2006 Dec; 192(6):705-709.
  7. Patton JH Jr et al. Use of human acellular dermal matrix in complex and contaminated abdominal wall reconstructions. Am J Surg. 2007 Mar;193(3):360-363; discussion 363.
  8. Butler CE et al. Pelvic, abdominal, and chest wall reconstruction with AlloDerm® in patients at increased risk for mesh-related complications. Plast Reconstr Surg. 2005 Oct;116(5): 1263-1275; discussion 1276-1277.
  9. Kish KJ et al. Acellular dermal matrix (AlloDerm®): new material in the repair of stoma site hernias. Am Surg. 2005 Dec;71(12):1047-1050.



Before use, physicians should review all risk information and essential prescribing information which can be found in the AlloDerm® Regenerative Tissue Matrix Instructions for Use. Physicians should also refer to the Instructions for Use for detailed preparation and implantation instructions.